SFS
ALXN

Sowell Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Sowell Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,026
Closed -$174K – 3159
2021
Q1 		$174K Sell
1,026
-45
-4% -$6.96K 0.01% 1122
2020
Q4 		$167K Buy
1,071
+130
+14% +$16.7K 0.01% 923
2020
Q3 		$108K Buy
941
+10
+1% +$1.08K 0.01% 948
2020
Q2 		$104K Buy
931
+13
+1% +$1.38K 0.01% 953
2020
Q1 		$82K Buy
918
+304
+50% +$29.8K 0.01% 910
2019
Q4 		$66K Buy
614
+64
+12% +$6.84K 0.01% 1056
2019
Q3 		$54K Buy
+550
New +$62K ﹤0.01% 976

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Sowell Financial Services's ALXN Position: Q2 2021 in Review

Sowell Financial Services sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 1,026 shares — an estimated $174K sold.

Sowell Financial Services first reported a position in ALXN in Q3 2019 and held it in 7 quarters. The position peaked at $174K in Q1 2021. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Sowell Financial Services reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,026 Alexion Pharmaceuticals shares in Q2 2021, an estimated $174K.
  • Sowell Financial Services first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Alexion Pharmaceuticals position peaked at $174K in Q1 2021.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.